Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2020 Jul:128:104424.
doi: 10.1016/j.jcv.2020.104424. Epub 2020 May 7.

SARS-CoV-2 and enhancing antibodies

Joachim Denner  1
Affiliations
Comment

SARS-CoV-2 and enhancing antibodies

Joachim Denner. J Clin Virol. 2020 Jul.
No abstract available

PubMed Disclaimer

Comment on

Similar articles

See all similar articles

Cited by

  • Evolution of Early SARS-CoV-2 and Cross-Coronavirus Immunity.
    Loos C, Atyeo C, Fischinger S, Burke J, Slein MD, Streeck H, Lauffenburger D, Ryan ET, Charles RC, Alter G. Loos C, et al. mSphere. 2020 Sep 2;5(5):e00622-20. doi: 10.1128/mSphere.00622-20. mSphere. 2020. PMID: 32878931 Free PMC article.
  • Antibody Responses in COVID-19: A Review.
    Chvatal-Medina M, Mendez-Cortina Y, Patiño PJ, Velilla PA, Rugeles MT. Chvatal-Medina M, et al. Front Immunol. 2021 Apr 15;12:633184. doi: 10.3389/fimmu.2021.633184. eCollection 2021. Front Immunol. 2021. PMID: 33936045 Free PMC article. Review.

References

    1. Killerby M.E., Biggs H.M., Haynes A., Dahl R.M., Mustaquim D., Gerber S.I., Watson J.T. Human coronavirus circulation in the United States 2014-2017. J. Clin. Virol. 2018;101:52–56. - PMC - PubMed
    1. Wang Q., Zhang L., Kuwahara K., Li L., Liu Z., Li T., Zhu H., Liu J., Xu Y., Xie J., Morioka H., Sakaguchi N., Qin C., Liu G. Immunodominant SARS coronavirus epitopes in humans elicited both enhancing and neutralizing effects on infection in non-human primates. ACS Infect. Dis. 2016;2(5):361–376. - PMC - PubMed
    1. Wan Y., Shang J., Sun S. Molecular mechanism for antibody-dependent enhancement of coronavirus entry. J. Virol. 2020;94(5):e02015–19. - PMC - PubMed
    1. Rey F.A., Stiasny K., Vaney M.C., Dellarole M., Heinz F.X. The bright and the dark side of human antibody responses to flaviviruses: lessons for vaccine design. EMBO Rep. 2018;19(2):206–224. - PMC - PubMed
    1. Shen C., Wang Z., Zhao F. Treatment of 5 critically ill patients with COVID-19 with convalescent plasma. JAMA. 2020 doi: 10.1001/jama.2020.4783. Mar 27. - DOI - PMC - PubMed

Substances